To find the role of sudarshan ghanvati and aarogyavardhini vati in Non alcoholic fatty liver disease patients

Comparative study to evaluate the efficacy of Sudarshan ghanvati and Aarogyavardhini Vati in disintegration of pathogenesis of non-alcoholic fatty liver disease- A Randomized control trial - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/081550

Enrollment

Registered

2025-03-03

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either gender between age of 21 to 65 years. 2. Diagnosed patients of NAFLD grade 1 and grade 2. 3. Patients willing to provide consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Pregnant women and lactating mothers. 2. Patients with serious cardiac or renal disorders. 3. Drug induced serious illness. 4. Patients suffering from Cirrhosis of liver.

Design outcomes

Primary

Measure	Time frame
1. USG - Whole Abdomen Timepoint: day0,day45	—

Secondary

Measure	Time frame
secondary Outcome 1. Liver Function testsTimepoint: 0day,day 45	—

Countries

India

Contacts

Public ContactDr Prahlad Kumar Prajapati

Chaudhary Brahm Prakash Ayurved Charak Sansthan

prhld230@gmail.com9993812112

Outcome results